---
schema_version: "secwatch.filing_event.v1"
accession: "0000070318-23-000006"
form_type: "8-K"
ticker: "THC"
cik: "0000070318"
company_name: "TENET HEALTHCARE CORP"
filed_at: "2023-02-09T23:59:59+00:00"
generated_at: "2026-06-19T21:07:11.887905+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Tenet Q4 net income $102M ($0.92 diluted EPS), FY2023 Adj. EBITDA guidance $3.16B-$3.36B

## Summary
- Q4 2022 net income from continuing ops $102M ($0.92 diluted EPS) vs $250M ($2.30) a year ago; adjusted diluted EPS $1.96 vs $2.70.
- Consolidated Q4 Adj. EBITDA $897M (incl $40M grant income) vs $1.017B; Ambulatory Adj. EBITDA ex-grant grew 18.7% to $407M.
- FY2023 outlook: Adj. EBITDA $3.16B-$3.36B, adjusted diluted EPS $4.68-$5.85; net operating revenues $19.7B-$20.1B.
- Repurchased 5.9M shares for $250M in Q4; entered deal to sell San Ramon Regional Medical Center for $142.5M (close expected 2023).

## SEC filing metadata
- accession: 0000070318-23-000006
- form_type: 8-K
- ticker: THC
- cik: 0000070318
- company_name: TENET HEALTHCARE CORP
- filed_at: 2023-02-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70318/000007031823000006/0000070318-23-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70318/000007031823000006/thc-20230209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000070318-23-000006
- JSON: https://secwatch.observer/filing/0000070318-23-000006.json
- Plain text: https://secwatch.observer/filing/0000070318-23-000006.txt

## Key facts
- Earnings Releases
  TENET HEALTHCARE CORP reported quarter ended December 31, 2022 results: revenue $4,990, net income $102 million, EPS $0.92 per diluted share.
  - Period: quarter ended December 31, 2022
  - Revenue: $4,990
  - Net income: $102 million
  - EPS: $0.92 per diluted share
  - Result: reported results
  source text: 2021 are as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2022 2021 2022 2021 Net operating revenues $4,990 $4,856 $19,174 $19,485 Net income available to Tenet common shareholders from continuing operations $102 $250 $410 $915 Net income available to Tenet common shareholders from
  evidence_url: https://www.sec.gov/Archives/edgar/data/70318/000007031823000006/0000070318-23-000006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.